There is no fulltext present in this item.

Find Full text  
Title: Neuroleptic malignant syndrome during zuclopenthixol therapy in X-linked cerebral adrenoleukodystrophy.
Author(s): Rubio Gozalbo, M.E. ; Waardenburg, D.A. van; Forget, P.P.; Spaapen, L.J.; Verrips, A. ; Vroomen, P.C.
Publication year: 2001
Source: Journal of Inherited Metabolic Disease, vol. 24, iss. 5, (2001), pp. 605--6
ISSN: 0141-8955
DOI: https://doi.org/10.1023/A:1012480130445
Publication type: Article / Letter to editor

Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/186866   https://hdl.handle.net/2066/186866

Display more details
Subject: Disturbances of cerebral development in the young child.
Pediatric Oncology. Treatment of children with cancer.
Pathophysiology of Brain and Behaviour
Cerebrale ontwikkelingsstoornissen bij het jonge kind
Kinderoncologie. Behandeling van kinderen met kanker.
Pathofysiologie van Hersenen en Gedrag
Organization: Paediatrics
Neurology
Journal title:
Journal of Inherited Metabolic Disease
Volume: vol. 24
Issue: iss. 5
Page start: p. 605-
Page end: p. 6
Abstract:
An 8 year-old boy with X-ALD under treatment with simvastatin developed a severe adverse reaction when the dose of his other medication, zuclopenthixol was increased. Both drugs were withdrawn after a diagnosis of neuroleptic malignant syndrome was made.

This item appears in the following Collection(s)

Browse

Statistics